Shagun Singh
Stock Analyst at RBC Capital
(3.31)
# 1,016
Out of 5,131 analysts
250
Total ratings
50.24%
Success rate
1.89%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Sector Perform | $90 → $68 | $59.76 | +13.79% | 10 | Feb 12, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $210 → $172 | $175.89 | -2.21% | 5 | Feb 10, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $130 → $115 | $74.73 | +53.89% | 19 | Feb 5, 2026 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $240 → $255 | $243.45 | +4.74% | 24 | Feb 3, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $147 → $135 | $112.68 | +19.81% | 18 | Jan 23, 2026 | |
| PEN Penumbra | Downgrades: Sector Perform | $355 → $374 | $339.30 | +10.23% | 16 | Jan 20, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $625 → $650 | $485.84 | +33.79% | 18 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $92 → $100 | $88.09 | +13.52% | 9 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $75.87 | +31.80% | 24 | Dec 5, 2025 | |
| PODD Insulet | Maintains: Outperform | $370 → $380 | $242.74 | +56.55% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $118 | $99.49 | +18.60% | 22 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $22 → $17 | $3.39 | +401.47% | 14 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $135 → $120 | $103.75 | +15.66% | 23 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $101 | $96.45 | +4.72% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $70.02 | +21.39% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $18.96 | +31.86% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $366.05 | +18.84% | 19 | Jan 29, 2025 |
Inspire Medical Systems
Feb 12, 2026
Maintains: Sector Perform
Price Target: $90 → $68
Current: $59.76
Upside: +13.79%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Sector Perform
Price Target: $210 → $172
Current: $175.89
Upside: -2.21%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $130 → $115
Current: $74.73
Upside: +53.89%
Johnson & Johnson
Feb 3, 2026
Maintains: Outperform
Price Target: $240 → $255
Current: $243.45
Upside: +4.74%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $147 → $135
Current: $112.68
Upside: +19.81%
Penumbra
Jan 20, 2026
Downgrades: Sector Perform
Price Target: $355 → $374
Current: $339.30
Upside: +10.23%
Intuitive Surgical
Dec 17, 2025
Maintains: Outperform
Price Target: $625 → $650
Current: $485.84
Upside: +33.79%
Globus Medical
Dec 17, 2025
Maintains: Outperform
Price Target: $92 → $100
Current: $88.09
Upside: +13.52%
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $75.87
Upside: +31.80%
Insulet
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $242.74
Upside: +56.55%
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $99.49
Upside: +18.60%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $3.39
Upside: +401.47%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $135 → $120
Current: $103.75
Upside: +15.66%
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $96.45
Upside: +4.72%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $70.02
Upside: +21.39%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $18.96
Upside: +31.86%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $366.05
Upside: +18.84%